Table 4. Significantly altered metabolites in diabetic participants following RDIF.
M/Z Ratio |
Fold Change |
Direction of change |
P-value |
KEGG ID |
Name of Metabolites |
Formula |
223 |
1.6726 |
Elevated |
0.004279 |
C05580 |
3,4-Dihydroxymandelate |
C8H8O5 |
C01236 |
6-Phospho-D-glucono-1,5-lactone |
C6H11O9P |
||||
C05585 |
Gentisate aldehyde (2,5-Dihydroxybenzaldehyde) |
C7H6O3 |
||||
206.4 |
1.7109 |
Elevated |
0.008624 |
C00032 |
Heme B |
C34H32FeN4O4 |
584.9 |
1.7293 |
Elevated |
0.01094 |
C11555 |
Inositol 1,4,5,6-tetrakisphosphate |
C6H16O18P4 |
C01272 |
Inositol 1,3,4,5-tetrakisphosphate |
C6H16O18P4
|
||||
C04477 |
Inositol 1,3,4,6-tetrakisphosphate |
C6H16O18P4 |
||||
C04520 |
Inositol 3,4,5,6-tetrakisphosphate |
C6H16O18P4
|
||||
498 |
1.7473 |
Elevated |
0.014602 |
C04895 |
7,8-Dihydroneopterin 3'-triphosphate |
C9H16N5O13P3 |
247 |
1.5152 |
Elevated |
0.016607 |
C01345 |
dITP(2'-Deoxyinosine-5'-triphosphate) |
C10H15N4O13P3 |
246 |
1.6719 |
Elevated |
0.019889 |
C01044 |
N-Formyl-L-aspartate |
C5H7NO5 |
522.1 |
1.5615 |
Elevated |
0.021162 |
C00325 |
GDP-L-fucose |
C16H25N5O15P2 |
275.1 |
1.7689 |
Elevated |
0.023775 |
C05841 |
Nicotinate D-ribonucleoside |
C11H14NO6 |
132 |
5.7269 |
Elevated |
0.02455 |
C01180 |
2-Keto-4-methylthiobutyric acid |
C5H8O3S |
383 |
1.8202 |
Elevated |
0.030924 |
C00105 |
Uridine 5'-monophosphate |
C9H13N2O9P |
210.1 |
1.8496 |
Elevated |
0.035603 |
C03150 |
N-Ribosylnicotinamide |
C11H15N2O5 |
106.1 |
0.66388 |
Reduced |
0.006604 |
C03771 |
5-Guanidino-2-oxopentanoate |
C6H11N3O3 |
Ramadan Diurnal Intermittent Fasting (RDIF)